Current Status of Growth Factor Use in Children
Session Date
Session Date:
January 12, 2021
Didactic
Didactic:
Beth Carter, MD
At the end of this activity, participants will be able to
At the end of this activity, participants will be able to:
- Summarize overall outcomes in children with GLP-2
- Outline the approach to use of GLp-2 analogs in children with SBS-IF
- Discuss real-world experience with GLP-2 use in pediatric patients with SBS-IF